Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    Zetia (ezetimibe)
    avatar
    UnkilPhuzzie posted:
    I realize that a little knowledge is a dangerous thing, but please indulge me for a moment. I am wondering if anyone knows of any research being conducted on treating HCV using telaprevir triple therapy in combination with the cholesterol lowering drug Ezetimibe, which I understand targets the NPC1L1 receptor recently identified as the entry point for HCV in liver cells.
    Reply
     
    avatar
    Haylen_WebMD_Staff responded:
    Here is a link to the WebMD resource to find information on medications and supplements:

    WebMD Drugs and Medication A - Z

    There are user reviews and you might find information about those involved in a trial during treatment.

    Haylen


    Helpful Tips

    New treatments for hepatitis CExpert
    I'll be appearing on Sirius Radio, channel 114 (on XM, channel 119) on Monday April 14, from 9-9:30 A.M. discussing the new protease ... More
    Was this Helpful?
    5 of 9 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.